.svg?rev=a492cc1069df46bdab38f8cb66573f1c&hash=2617C9FE8A7B0BD1C43269B5D5ED9AE2)
Pharmaceuticals & Biologics
Overview
By bringing innovative products to market, pharmaceutical companies help people live longer, higher-quality lives — and our attorneys and other professionals are dedicated to facilitating that progress. Our professionals include former in-house counsel and senior executives for some of the world’s largest pharmaceutical companies, as well as an interdisciplinary team of experienced attorneys and professionals who provide regulatory, transactional, litigation, intellectual property and government affairs services tailored to the pharmaceutical industry. We help clients tackle business and financing pressures, regulatory scrutiny and litigation threats on a national and international scale. We have steered global pharma companies through multibillion-dollar transactions and helped international drug manufacturers accelerate drug development through creative joint ventures. Our IP attorneys work to patent your inventions in countries around the globe; shield your brands through trademark policing and anti-counterfeiting strategies; and negotiate commercial, licensing and other strategic agreements — freeing you to focus on product development and innovation. We serve as outside general counsel for regulatory compliance matters and support on all interactions with the Food and Drug Administration and other regulatory parties, including inspections, investigations and enforcement. And when disputes occur, our trial lawyers are there to handle any issue. Whether enforcing your rights or defending against alleged wrongdoing, including in product liability litigation, our team of skilled trial attorneys is ready to represent you in high-stakes, bet-the-company litigation every day.
Insights & Events
Latest
FDA Launches Dashboard to Provide Access to Real-Time Adverse Event Data for Cosmetics
FDA’s Prioritization Pilot Providing Faster Review When Generic Drugs — APIs or Finished Products — Are Produced Domestically
Effects of the One Big Beautiful Bill Act on Health Care and Pharma; and More
Bench & Bar of Minnesota Highlights New MSBA President Tom Pack’s Approach to Leadership
Faegre Drinker Strengthens Nationwide Product Liability & Mass Torts Practice, Adding Medical Device Litigator Dan Smulian in New York
AI Policy and the New Administration: Implications for FDA-Regulated Industries
Is This the Death Knell of Strict Liability Crimes?
Faegre Drinker Grows Life Sciences Consulting Team With Nationally Recognized Patient Experience Researcher Holly Peay, PhD
Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News
Managed Care, Enforcement and Compliance
Insights
FDA Launches Dashboard to Provide Access to Real-Time Adverse Event Data for Cosmetics
FDA’s Prioritization Pilot Providing Faster Review When Generic Drugs — APIs or Finished Products — Are Produced Domestically
Effects of the One Big Beautiful Bill Act on Health Care and Pharma; and More
Bench & Bar of Minnesota Highlights New MSBA President Tom Pack’s Approach to Leadership
Is This the Death Knell of Strict Liability Crimes?
Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News
HHS and FDA Launch RFI on Deregulatory Plan — A Key Opportunity to Shape Health and Food Policy
How do we put Meaning Into Meaningful Benefit? Perspectives From the Lived Experience
FDA Identifies Data Quality and Study Conduct Concerns With Raptim Research and Requires Sponsors to Submit Replacement Study Data
The Hidden Dangers of Alternative Funding Programs
Events
Past Events
AI Policy and the New Administration: Implications for FDA-Regulated Industries
Managed Care, Enforcement and Compliance
Federal and State Enforcement of Private Equity Investment in Health Care
Telehealth Law & Policy
AHM v. FDA: The Litigation and its Ripple Effects Across the Health Care and Life Sciences Sectors - New York, NY
News
Faegre Drinker Strengthens Nationwide Product Liability & Mass Torts Practice, Adding Medical Device Litigator Dan Smulian in New York
Faegre Drinker Grows Life Sciences Consulting Team With Nationally Recognized Patient Experience Researcher Holly Peay, PhD
Faegre Drinker Grows Customs & International Trade Practice in Washington, D.C., Welcoming Prominent Trade Enforcement Partner Daniel Wilson
Faegre Drinker Welcomes Former Senate HELP Committee General Counsel Barrett Tenbarge to Government and Regulatory Group
Faegre Drinker Welcomes Partner Greg Mitchell, Life Sciences Patent Team to Intellectual Property Practice
Faegre Drinker Welcomes Life Sciences Litigator Tom Pack to California Product Liability & Mass Torts Team
Faegre Drinker Announces 2025 Partner Class and New Counsel Promotions
Three Former Federal Prosecutors Join Faegre Drinker’s White Collar Team
Faegre Drinker Advises Ansell Healthcare Products in Acquisition of Kimberly-Clark’s Personal Protective Equipment Business in Over 40 Countries
Faegre Drinker Grows in Los Angeles With Class Actions and Commercial Litigator Josh Anderson
Experience
Our Experience
Faegre Drinker Team Secures Favorable Ruling for Regeneron in FCA Kickback Case
Pharmaceutical Company Enforces Trademarks
National Association of Boards of Pharmacy Focuses on Legal and Policy Matters
Merck Animal Health Acquires Virtual Fencing Company Vence Corp
Tyme Technologies Completes Merger With Syros Pharmaceuticals
Fortune 500 Life Sciences Companies Outsource Leave and Disability Program Administration
Meet The Team
Meet The Full Pharmaceuticals & Biologics Team
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Terry L. Frangiosa
Principal - Faegre Drinker Consulting -
Timothy R. Franson, M.D.
Principal - Faegre Drinker Consulting -
-
Mary Susan Gerber
Intellectual Property Attorney -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Amy Ramsey Marcos
Senior Information Governance Attorney -
-
-
-
-
-
-
-
-
-
-
Ilse Peterson, MPH
Director - Research & Strategy -
-
-
William L. Roberts
General Counsel / Partner -
-
-
Fatou Hann Sarr
Manager - Research & Policy -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
